Abstract
Positron emission tomography (PET) neuroimaging is an advanced nuclear medicine technology that allows visualization of functional brain activity in vivo. The current advances in the technology have allowed a high degree of temporal and spatial resolution, permitting the measurement of transient brain events (seconds) over relatively small brain regions. As such, the method has been a valuable tool for neuropsychological investigations of human cognition. In addition, PET imaging has been used clinically to facilitate the diagnosis of suspected brain dysfunction (Friedland, 1989; Workshop Panel, 1990). The method has been clinically useful, particularly in cases where the diagnosis is unclear, such as in the early stages of Alzheimer’s disease (AD). The purpose of this chapter is to review the use of PET imaging in dementia. Within this chapter we explore the uses of PET imaging in Alzheimer’s disease and other dementias of late life. The text of this chapter is divided into six sections. The first section provides an overview of the fundamental principles of PET neuroimaging. The next section discusses the contribution of PET imaging to the understanding of normal aging and Alzheimer’s disease, the most common cause of dementia in the elderly. The functional imaging changes observed in other common forms of dementia are discussed in the next three sections. We start by considering the vascular dementias, move to discussion of the subcortical dementias (Huntington’s disease, Parkinson’s disease, and progressive supranuclear palsy), and conclude with a description of the PET findings in less common cortical dementias, namely, Pick’s disease and Creutzfeldt-Jakob disease. In the final section, the limitations of the PET method alone in the diagnosis of dementia are discussed and the future directions of PET imaging in the clinical arena are considered. Within this last section of the text, we entertain the relative utility of combining methodologies, neuropsychological evaluation, and functional brain imaging-PET as clinical predictors of Alzheimer’s disease and other dementias.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Absher, J. R., & Benson, D. F. (1993). Disconnection syndromes: An overview of Geschwind’s contributions. Neurology, 43, 862–867.
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neuroflbrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cerebral Cortex, 1, 103–116.
Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology, 42, 1681–1688.
Azari, N. P., Pettigrew, K. D., Schapiro, M. B., Haxby, J. V., Grady, C. L., Pietrini, P., Salerno, J. A., Heston, L. L., Rapoport, S. I., & Horwitz, B. (1993). Early detection of Alzheimer’s disease: A statistical approach using positron emission tomographic data. Journal of Cerebral Blood Flow and Metabolism, 13, 438–447.
Baron, J. C., Bousser, M. G., Comar, D., & Castaigne, P. (1980). Crossed cerebellar diaschisis in human supratentorial brain infarction. Annals of Neurology, 8, 128.
Baron, J. C., D’Antona, R., Pantano, P., Serdaru, M., Samson, Y., & Bousser, M. G. (1986). Effects of thalamic stroke on energy metabolism of the cerebral cortex: A positron emission tomography study in man. Brain, 109, 1243–1259.
Baron, J. C., Maziere, B., Lo’ch, C., Sgouropoulos, P., Bonnet, A. W., & Agid, Y. (1985). Progressive supranuclear palsy: Loss of striatal dopamine receptors demonstrated by positron tomography. Lancet, 1, 1163–1164.
Bennett, D. A., Wilson, R. S., Gilley, D. W., & Fox, J. H. (1990). Clinical diagnosis of Binswanger’s disease. Journal of Neurology, Neurosurgery, & Psychiatry, 53, 961–965.
Benson, D. F., Kuhl, D. E., Hawkins, R. A., Phelps, M. E., Cummings, J. L., & Tsai, S. Y. (1983). The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Archives of Neurology, 40, 711–714.
Bernheimer, H., Birkmeyer, W., Hornykiewicz, O., Mellinger, K., & Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. Journal of the Neurological Sciences, 20, 415–445.
Bhatt, M. H., Snow, B. J., Martin, W. R. W., Peppard, R., & Calne, D. B. (1991). Positron emission tomography in progressive supranuclear palsy. Archives of Neurology, 48, 389–391.
Blessed, D. G., Tomlinson, B. E., & Roth, M. (1968). The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. British Journal of Psychiatry, 114, 797–811.
Boone, K. B., Miller, B. L., Lesser, I. M., Mehringer, M., Hill-Gutierrez, E., Goldberg, M. A., & Berman, N. G. (1992). Neuropsychological correlates of white-matter lesions in healthy elderly subjects: A threshold effect. Archives of Neurology, 49, 549–554.
Bradshaw, J. L., Phillips, J. G., Dennis, C., Mattingley, J. B., Andrewes, D., Chiu, E., Pierson, J. M., & Bradshaw, J. A. (1992). Initiation and execution of movement sequences in those suffering from and at risk of developing Huntington’s disease. Journal of Clinical and Experimental Neuropsychology, 14, 179–192.
Brooks, D. J., Playford, E. D., Ibanez, V., Sawle, G. V., Thompson, P. D., Findley, L. J., & Marsden, C. D. (1992). Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study. Neurology, 42, 1554–1560.
Brouwers, P., Cox, C., Martin, A., Chase, T., & Fedio, P. (1984). Differential perceptual-spatial impairment in Huntington’s and Alzheimer’s dementias. Archives of Neurology, 41, 1073–1076.
Brown, P., Goldfarb, L. G., McCombie, W. R., Nieto, A., Squillacote, D., Sheremata, W., Little, B. W., Godec, M. S., Gibbs, C. J., & Gajdusek, D. C. (1992). Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology, 42, 422–427.
Butters, N., Granholm, E., Salmon, D. P., Grant, I., & Wolfe, J. (1987). Episodic and semantic memory: A comparison of amnesic and demented patients. Journal of Clinical and Experimental Neuropsychology, 9, 479–497.
Butters, N., Sax, D., Montgomery, K., & Tarlow, S. (1978). Comparison of the neuropsychological deficits associated with early and advanced Huntington’s disease. Archives of Neurology, 35, 585–589.
Butters, N., Wolfe, J., Martone, M., Granholm, E., & Cermak, L. S. (1985). Memory disorders associated with Huntington’s disease: Verbal recall, verbal recognition, and procedural memory. Neuropsychologia, 23, 729–743.
Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., James, N. M., Kronfol, Z., Lohr, N., Steiner, M., deVigne, J. P., & Young, E. (1981). A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Archives of General Psychiatry, 38, 15–22.
Chase, T. N., Burrows, H., & Mohr, E. (1987). Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type. Archives of Gerontology and Geriatrics, 6, 289–297.
Chase, T. N., Fedio, P., Foster, N. L., Brooks, R., Di Chiro, G., & Mansi, L. (1984a). Wechsler Adult Intelligence Scale performance: Cortical localization by fluorodeoxyglucose F18-positron emission tomography. Archives of Neurology, 41, 1244–1247.
Chase, T. N., Foster, N. L., Fedio, P., Brooks, R., Mansi, L., & Di Chiro, G. (1984b). Regional cortical dysfunction in Alzheimer’s disease as determined by positron emission tomography. Annals of Neurology, 15 (Suppl), S170–174.
Chawluk, J. B., Dann, R., Alavi, A., Hurtig, H. I., Gur, R. E., Resnick, S., Zimmersman, R. A., & Reivick, M. (1990). The effect of focal cerebral atrophy in position emission tomography studies of aging and dementia. Nuclear Medicine and Biology, 17, 797–804.
Chawluk, J. B., Mesulam, M. M., Hurtig, H., Kushner, M., Weintraub, S., Saykin, A., Rubin, N., Alavi, A., & Reivich, M. (1986). Slowly progressive aphasia without generalized dementia: Studies with positron emission tomography. Annals of Neurology, 19, 68–74.
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992). Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology, 42, 473–480.
Clark, C. M., Carson, R., Kesseler, R., Margolin, R., Buchsbaum, M., Delisi, L., King, C., & Cohen, R. (1985). Alternative statistical models for the examination of clinical positron emission tomography/fluorodeoxyglucose data. Journal of Cerebral Blood Flow and Metabolism, 5, 142–150.
Crapper-McLachlan, D. R., Dalton, A. J., Galin, H., Schlotterer, G., & Dakar, E. (1984). Alzheimer’s disease: Clinical course and cognitive disturbances. Acta Neurologica Scandinavica, 99, 83–89.
Cummings, J. L. (1990). Subcortical dementia. New York: Oxford University Press.
Cutler, N. (1988). Utility of biological markers in the evaluation and diagnosis of Alzheimer’s disease. Brain Dysfunction, 1, 12–31.
Cutler, N. R., Haxby, J. V., Duara, R., Grady, C. L., Moore, A. M., Parisi, J. E., White, J., Heston, L., Margolin, R. M., & Rapoport, S. I. (1985). Brain metabolism as measured with positron emission tomography: Serial assessment in a patient with familial Alzheimer’s disease. Neurology, 35, 1556–1561.
Dannals, R. F. (1989). Synthesis of radiotracers. Journal of Neuropsychiatry and Clinical Neurosciences, 1 (Suppl), S14–S18.
D’Antona, R., Baron, J. C., Samson, Y., Serdaru, M., Viader, F., Agid, Y, & Cambier, J. (1985). Subcortical dementia. Frontal cortex hypometabolism detected by positron emission tomography in patients with progressive supranuclear palsy. Brain, 108, 785–799.
Davis, P. H., Bergeron, C., & McLachlan, D. R. (1985). Atypical presentation of progressive supra-nuclear palsy. Annals of Neurology, 17, 343–373.
de Leon, M. J., Ferris, S. H., George, A. E., Reisberg, B., Christman, D. R., Kricheff, I. I., & Wolf, A. P. (1983). Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer’s disease. Journal of Cerebral Blood Flow and Metabolism, 3, 391–394.
de Leon, M. J., George, A. E., Ferris, S. H., Christman, D. R., Fowler, J. S., Gentes, C. I., Brodie, J., Reisberg, B., & Wolf, A. P. (1984). Positron emission tomography and computed tomography assessments of the aging human brain. Journal of Computer Assisted Tomography, 8, 88–94.
Duara, R., Barker, W. W., Chang, J., Yoshii, F., Loewenstein, D. A., & Pascal, S. (1992). Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer’s disease. Journal of Cerebral Blood Flow and Metabolism, 12, 927–934.
Duara, R., Barker, W, Loewenstein, D., Pascal, S., & Bowen, B. (1989). Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer’s disease and multi-infarct dementia. European Neurology, 29, 9–15.
Duara, R., Grady, C., Haxby, J., Ingvar, D., Sokoloff, L., Margolin, R., Manning, R. G., Cutler, N. R., & Rapoport, S. I. (1984). Human brain glucose utilization and cognitive function in relation to age. Annals of Neurology, 16, 702–713.
Duara, R., Grady, C., Haxby, J., Sundaram, M., Cutler, N. R., Heston, L., Moore, A., Schlageter, N., Larson, S., & Rapoport, S. I. (1986). Positron emission tomography in Alzheimer’s disease. Neurology, 36, 879–887.
Duara, R., Loewenstein, D. A., & Barker, W. W. (1990). Utilization of behavioral activation paradigms for positron emission tomography studies in normal young and elderly subjects and in dementia. In R. Duara (Ed.), Positron emission tomography in dementia. Frontiers of clinical neuroscience: Vol. 10 (pp. 131–148). New York: Wiley-Liss.
Duara, R., Margolin, R. A., Roberson-Tchabo, E. A., London, E. D., Schwartz, M., Renfrew, J. W, Koziarz, B. J., Sundaram, M., Grady, C., Moore, A. M., Ingvar, D. H., Sokoloff, L., Weingartner, H., Kessler, R. M., Manning, R. G., Channing, M. A., Cutler, N. R., & Rapoport, S. I. (1983). Cerebral glucose utilization as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain, 106, 761–775.
Cummings, J. L., & Benson, D. F. (1984). Subcortical dementia: Review of an emerging concept. Archives of Neurology, 41, 874–879.
Duvoisin, R. C., Golbe, L.L, & Lepore, F. E. (1987). Progressive supranuclear palsy. Canadian Journal of Neurological Sciences, 14, 547–554.
Evans, D. A., Funkenstein, H. H., Albert, M. S., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., & Taylor, J. O. (1989). Prevalence of Alzheimer’s disease in a community sample of older persons: Higher than previously reported. Journal of the American Medical Association, 262, 2251–2556.
Fazio, F., Perani, D., Gilardi, M. C., Colombo, F., Cappa, S. F., Vallar, G., Bettinardi, V., Paulesu, E., Alberoni, M., Bressi, S., Franceschi, M., & Lenzi, G. L. (1992). Metabolic impairment in human amnesia: A PET study of memory networks. Journal of Cerebral Blood Flow and Metabolism, 12, 353–358.
Fischer, P., Jellinger, K., Gatterbi, G., & Danielcyzk, W. (1991). Prospective neuropathological validation of Hachinski’s ischaemic score in dementias. Journal of Neurology, Neurosurgery, & Psychiatry, 54, 580–583.
Folstein, S. E., Abbott, M. H., Chase, G. A. Jensen, B. A., & Folstein, M. F. (1983). The association of affective disorder with Huntington’s disease in a case series and in families. Psychological Medicine, 13, 537–542.
Folstein, S. E., Brandt, J., & Folstein, M. R. (1990). Huntington’s disease. In J. Cummings (Ed.), Subcortical dementia (pp. 87–107). New York: Oxford University Press.
Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & DiChiro, G. (1984). Cortical abnormalities in Alzheimer’s disease. Annals of Neurology, 16, 649–654.
Foster, N. L., Chase, T. N., Patronas, N.J., Gillespie, M. M., & Fedio, P. (1986). Cerebral mapping of apraxia in Alzheimer’s disease by positron emission tomography. Annals of Neurology, 19, 139–143.
Fox, P. T., Miezin, F. M., Allman, J. M., Van Essen, D. C., & Raichle, M. E. (1987). Retinotopic organization of the human visual cortex mapped with positron emission tomography. Journal of Neuroscience, 7, 913–922.
Fox, P. T., Mintun, M. A., Raichle, M. E., Miezin, R. M., Allman, J. M., & Van Essen, D. C. (1986). Mapping human visual cortex with positron emission tomography. Nature, 323, 806–809.
Frackowiak, R. S. J., Lenzi, G. L., Jones, T., & Heather, J. D. (1980). Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: Theory, procedure, and normal values. Journal of Computer Assisted Tomography, 4, 727–736.
Frackowiak, R. S. J., Pozzili, C., Legg, N. N.J., Du Boulay, G. H., Marshall, J., Lenzi, G. L., & Jones, T. (1981). Regional cerebral ozygen supply and utilization in dementia: A clinical and physiological study with oxygen-15 and positron emission tomography. Brain, 104, 753–778.
Freedman, M. (1990). Parkinson’s disease. InJ. Cummings (Ed.), Subcortical dementia (pp. 108–122). New York: Oxford University Press.
Frey, K. A., Koeppe, R. A., Mulholland, G. K., Jewett, D., Hichwa, R., Ehrenkaufer, R. L. E., Carey, J. E., Wieland, D. M., Kuhl, D. E., & Agranoff, B. W. (1992). In vivo muscarinic cholinergic receptor imaging in human brain with [11C] scopolamine and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 12, 147–154.
Friedland, R. P. (1989). Positron emission tomography in dementia. Seminars in Neurology, 150, 735–739.
Friedland, R. P., Budinger, T. F., Ganz, E., Yano, Y, Maathid, C. A., Koss, E., Ober, B. A., Huesman, R. H., & Derenzo, S. E. (1983). Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with [18F]-fluoro-deoxyglucose. Journal of Computer Assisted Tomography, 7, 590–598.
Friedland, R. P., Pruisner, S. B., Jagust, W. J., Budinger, T. F., & Davis, R. L. (1984). Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. Journal of Computer Assisted Tomography, 8, 978–981.
Fuld, P. A., Masur, D. M., Blau, A. D., Crystal, H., & Aronson, M. K. (1990). Object-memory evaluation for prospective detection of dementia in normal functioning elderly: Predictive and normative data. Journal of Clinical and Experimental Neuropsychology, 12, 539–548.
Garnett, E. S., Firnau, G., Nahmias, C., Carbotte, R., & Bartolucci, G. (1984). Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington’s disease. Journal of the Neurological Sciences, 65, 231–237.
Geschwind, N. (1965). Disconnexion syndromes in animals and man, Parts I and II. Brain, 88, 237–294, 585-644.
Gibb, W. R. G. (1986). Idiopathic Parkinson’s disease and the Lewy body disorders. Neuropathology and Applied Neurobiology, 12, 223–234.
Goffinet, A. M., De Voider, A. G., Gullain, C., Rectem, D., Bol, A., Michel, C., Cogneau, M., Labar, D., & Laterre, C. (1989). Positron tomography demonstrated frontal lobe hypometabolism in progressive supranuclear palsy. Annals of Neurology, 25, 131–139.
Grady, C. L., Haxby, J. V., Horwitz, B., Sundaram, M., Berg, G., Schapiro, M., Friedland, R. P., & Rapoport, S. I. (1988). Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. Journal of Clinical and Experimental Neuropsychology, 10, 579–596.
Grady, C. L., Haxby, J. V., Schapiro, M. B., Gonzalez-Aviles, A., Kumar, A., Ball, M. J., Heston, L., & Rapoport, S. I. (1990). Subgroups in dementia of the Alzheimer type identified using positron emission tomography. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 373–384.
Graff-Radford, N. R., Damasio, A. R., Hyman, B. T., Hart, M. N., Tranel, D., Damasio, H., Van Hoesen, G. W., & Rezai, K. (1990). Progressive aphasia in a patient with Pick’s disease: A neuropsychological, radiologic, and anatomic study. Neurology, 40, 620–626.
Grafton, S. T., Mazziotta, J. C., Pahl, J. J., St.George-Hyslop, P., Haines, J. L., Gusella, J., Hoffman, J. M., Baxter, L. R., & Phelps, M. E. (1990). A comparison of neurological, metabolic structural, and genetic evaluations in persons at risk for Huntington’s disease. Annals of Neurology, 28, 614–621.
Grafton, S. T., Mazziotta, J. C., Pahl, J. J., St.George-Hyslop, P., Haines, J. L., Gusella, J., Hoffman, J. M., Baxter, L. R., & Phelps, M. E. (1992). Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington’s disease. Archives of Neurology, 49, 1161–1167.
Greenberg, J. H., Reivich, M., Alavi, A., Hand, P., Rosenquist, A., Rintelmann, W., Stein, A., Tusa, R., Dann, R., Christman, D., Fowler, J., MacGregor, B., & Wolf, A. (1981). Metabolic mapping of functional activity in human subjects the [18F]fluorodeoxyglucose technique. Science, 212, 678–680.
Gur, R. C., Gur, R. E., Rosen, A. D., Warach, S., Alavi, A., Greenberg, J., Reivich, M. (1983). A cognitive-motor network demonstrated by positron emission tomography. Neurospychologia, 21, 601–606.
Gusella, J. F., Wexler, N. S., Conneally, P. M., Nayler, S. L., Anderson, M. A., Tanki, R. E., Watkins, P. C., Ottina, Wallace, M. R., Sakaguchi, A. Y., Young, A. B., Shoulson, I., Bonilla, E., & Martin, J. B. (1983). A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 306, 234–238.
Guze, B. H., Hoffman, J. M., Baxter Jr., L. R., Mazziota, J. C., & Phelps, M. E. (1991). Functional brain imaging in Alzheimer-type dementia. Alzheimer Disease and Associated Disorders, 5, 215–230.
Hachinski, V. C., Lassen, N. A., & Marshall, J. (1974). Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet, 2, 207–210.
Hagglund, J., Aquilonius, S.-M., Eckernas, S.-A., Hartvig, P., Lundquist, H., Gullberg, P., & Lang-strom, B. (1987). Dopamine receptor properties in Parkinson’s disease and Huntington’s chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone. Acta Neurologia Scandinavica, 75, 87–94.
Hakim, A. M., & Mathieson, G. (1979). Dementia in Parkinson’s disease: A neuropathologic study. Neurology, 29, 1209–1214.
Hansen, L. A., DeTeresa, R., Davies, P., & Terry, R. D. (1988). Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer’s disease. Neurology, 38, 48–54.
Harrison, P. J., & Roberts, G. W. (1991). “Life Jim, but not as we know it?” Transmissible dementias and the prion protein. British Journal of Psychiatry, 158, 457–470.
Haxby, J. V., Duara, R., Grady, C. L., Cutler, N. R., & Rapoport, S. I. (1985). Relations between neuropsychological and cerebral metabolism asymmetries in early Alzheimer’s disease. Journal of Cerebral Blood Flow Metabolism, 5, 193–200.
Haxby, J. V., Grady, C. L., Duara, R., Schlageter, N., Berg, G., & Rapoport, S. I. (1986). Neocortical metabolic abnormalities precede nonmemory cognitive deficits in early Alzheimer’s type dementia. Archives of Neurology, 43, 882–885.
Haxby, J. V., Grady, C. L., Koss, E., Horowitz, B., Heston, L., Schapiro, M., Friedland, R. P., & Rapoport, S. I. (1990). Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Archives of Neurology, 47, 753–760.
Haxby, J. V., Grady, C. L., Koss, E., Horowitz, B., Schapiro, M., Friedland, R. P., & Rapoport, S. I. (1988). Heterogenous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology, 38, 1853–1863.
Haxby, J. V., Grady, C. L., Ungerleider, L. G., & Horwitz, B. (1991). Mapping the functional neuroanatomy of the intact human brain with brain work imaging. Neuropsychologia, 29, 539–555.
Hayden, M. R., Hewitt, J., Stoessl, A. J., Clark, C., Ammann, W, & Martin, W. R. W. (1987). The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington’s disease. Neurology, 37, 1441–1447.
Hayden, M. R., Martin, W. R. W., Stoessl, A. J., Clark, C., Hollenberg, S., Adam, M. J., Ammann, W., Harrop, R., Rogers, J., Ruth, T., Sayre, C., & Pate, B. D. (1986). Positron emission tomography in the early diagnosis of Alzheimer’s disease. Neurology, 36, 888–894.
Hefter, J., Hamberg, V., Lange, H. W., & Freud, H.-J. (1987). Impairment of rapid movement in Huntington’s disease. Brain, 110, 585–612.
Heiss, W.-D., Vyska, K., Kloster, G., Traupe, H., Freundlieb, C., Hoeck, A., Feinendegen, L. E., & Stoecklin, G. (1982). Demonstration of decreasaed functional activity of visual cortex by 11C-methylglucose and positron emission tomography. Neuroradiology, 23, 45–47.
Heston, L. L., & Mastri, A. R. (1982). Age at onset of Pick’s and Alzheimer’s dementia: Implications for diagnosis and research. Journal of Gerontology, 4, 422–424.
Hoffman, J. M., Guze, B. H., Baxter, L. R., Mazziotta, J. C., & Phelps, M. E. (1989). [18F]-fluoro-deoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia: A decade of studies. European Neurology, 29 (Suppl. 3), 16–24.
Hoffman, J. M., Hanson, M. W., & Coleman, R. E. (1993). Clinical positron emission tomography imaging. Radiological Clinics of North America, 31, 935–959.
Hoffman, J. M., Welsh, K. A., Hanson, M. W., Earl, N., & Coleman, R. E. (1992). FDG-PET is useful in early detection and confirmation of Alzheimer’s disease (AD). Neurology, 42 (Suppl. 3), 315.
Holland, A. J., McBurney, D. H., Moossy, J., & Reinmuth, O. M. (1985). The dissolution of language in Pick’s disease with neuroflbrillary tangles: A case study. Brain and Language, 24, 36–58.
Horowitz, S., Benson, D. F., Kuhl, D. E., & Cummings, J. L. (1992). FDG scan to confirm Creutzfeldt-Jakob diagnosis (abstract). Neurology, 32, A167.
Hudson, A. J. (1981). Amyotrophic lateral sclerosis and its association with dementia, parkinsonism, and other neurological disorders: A review. Brain, 104, 217–247.
Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosome. Cell, 72, 971–983.
Hyman, B. T., Van Hoesen, G. W., Damaisio, A. R., & Barnes, C. L. (1984). Alzheimer’s disease: Cell-specific pathology isolates the hippocampal formation. Science, 225, 1168–1170.
Jagust, W. J., & Eberling, J. L. (1991). MRI, CT., SPECT., PET: Their use in diagnosing dementia. Geriatrics, 46, 28–35.
Jellinger, K., Riederer, P., & Tomonga, M. (1980). Progressive supranuclear palsy: Clinicopathological and biochemical studies. Journal of Neural Transactions Supplement, 16, 111–128.
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1988). Clinically diagnosed Alzheimer’s disease: Autopsy rersults in 150 cases. Annals of Neurology, 24, 50–56.
Jolles, P. R., Chapman, P. R., & Alavi, A. (1989). PET., CT., and MRI in the evaluation of neuropsychiatric disorders: Current applications. Journal of Nuclear Medicine, 30, 1589–1606.
Josiassen, R. C., Curry, L. M., & Mancall, E. L. (1983). Development of neuropsychological deficits in Huntington’s disease. Archives of Neurology, 40, 791–796.
Kamo, H., McGeer, P. L., Harrop, R., McGeer, E. G., Calne, D. B., Martin, W. R. W., & Pate, B. D. (1987). Positron emission tomography and histopathology in Pick’s disease. Neurology, 37, 439–445.
Kannel, W. B., Dawber, T. R., Sorlie, P., & Wolf, P. A. (1976). Component blood pressure and risk of atherothrombotic brain infarct: The Framingham study. Stroke, 7, 327–331.
Karbe, H., Holthoff, V., Huber, H., Herholz, K., Wienhard, K., Wagner, R., & Heiss, W.-D. (1992). Positron emission tomography in degenerative disorders of the dopaminergic system. Journal of Neural Transmission, 4, 121–130.
Katzman, R. (1986). Alzheimer’s disease. New England Journal of Medicine, 314, 217–218.
Katzman, R., Aronson, M., Fuld, P. A., Kawas, C., Brown, T., Morgenstern, H., Frishman, W, Gidez, L., Eder, H., & Ooi, W. L. (1989). Development of dementing illness in an 80-year-old volunteer cohort. Annals of Neurology, 25, 317–324.
Kessler, I. I. (1978). Parkinson’s disease in epidemiological perspective. In B. S. Schoenberg (Ed.), Advances in neurology: Vol. 19 (pp. 355–384). New York: Raven Press.
Kessler, J., Herholz, K., Grond, M., & Heiss, W.-D. (1991). Impaired metabolic activation in Alzheimer’s disease: A PET study during continuous visual recognition. Neuropsychologia, 29, 229–243.
Khachaturian, Z. S. (1985). Diagnosis of Alzheimer’s disease. Archives of Neurology, 42, 1097–1105.
Knopman, D. S., Christensen, K. J., Schut, L. J., Harbaugh, R. E., Reeder, T., Ngo, T., & Frey, W (1989). The spectrum of imaging and neuropsychological findings in Pick’s disease. Neurology, 39, 362–368.
Knopman, D. S., & Ryberg, S. (1989). A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Archives of Neurology, 46, 141–145.
Kooistra, C. A., & Heilman, K. M. (1988). Memory loss from a subcortical white matter infarct. Journal of Neurology, Neurosurgery, & Psychiatry, 51, 866–869.
Kosaka, K., Yoshimira, M., Ikeda, K., & Budka, H. (1984). Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: A new disease? Clinical Neuropathology, 3, 185–192.
Koss, E., Freidland, R. P., Ober, B. A., & Jagust, W. J. (1985). Differences in lateral hemispheric asymmetries of glucose utilization between early and late onset Alzheimer-type dementia. American Journal of Psychiatry, 142, 638–640.
Kuhl, D. E., Metter, E. J., & Riege, W. H. (1985). Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer’s disease. In L. Sokoloff (Ed.), Brain imaging and brain function: Vol. 63 (pp. 211–226). New York: Raven Press.
Kuhl, D. E., Metter, E. J., Riege, W. H., & Markham, C. H. (1984). Patterns of cerebral glucose utilization in Parkinson’s disease and Huntington’s disease. Annals of Neurology, 15(Suppl.), S119–125.
Kuhl, D. E., Metter, E. J., Riege, W, H., & Phelps, M. E. (1982). Effects of human aging on patterns of local cerebral glucose utilization determined by (18F) fluorodeoxyglucose method. Journal of Cerebral Blood Flow Metabolism, 2, 163–171.
Kuhl, D. E., Phelps, M. E., Kowell, A. P., Metter, E. J., Selin, C., & Winter, J. (1980). Effect of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18FDG and 13NH3. Annals of Neurology, 8, 47–60.
Kuhl, D. E., Small, G. W., Riege, W. H., Fujikawa, D. G., Metter, E. J., Benson, D. F., Ashford, J. W., Mazziotta, J. C., Maltese, A., & Dorsey, D. A. (1987). Cerebral metabolic patterns before the diagnosis of probable Alzheimer’s disease. Journal of Cerebral Blood Flow and Metabolism, 7, S406.
Kuwert, T., Lange, H. W., Langen, K.-J., Herzog, H., Aulick, A., & Feinendegen, L. E. (1990). Cortical and subcortical glucose consumption measured by PET in patients with Huntington’s disease. Brain, 113, 1405–1423.
Kwong, K. K., Belliveau, J. W., Chester, D. A., Goldberg, I. E., Weissfoff, R. M., Poncelet, B. P., Kennedy, D. N., Hoppel, B. E., Cohen, M. S., Turner, R., Cheng, H.-M., Brady, T. J., & Rosen, B. R. (1992). Dyanmic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proceedings of the National Academy of Science, 89, 5675–5679.
Larson, D. B., Lyons, J. S., Bareta, J. C., Burns, B. J., Blazer, D. G., & Goldstrom, I. D. (1988). The construct validity of the ischemic score of Hachinski for the detection of dementias. Journal of Neuropsychiatry, 1, 181–187.
Leenders, K. L., Palmer, A. J., Quinn, N., Clark, J. C., Firnau, G., Garnett, E. S., Nahmias, C., Jones, T., & Marsden, C. D. (1986). Brain dopamine metabolism in patients with Parkinson’s diseasae measured with positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry, 49, 853–860.
Leuchter, A. F., Newton, T. F., Cook, I. A., Walter, D. O., Rosenberg-Thompson, S., & Lachenbruch, P. A. (1992). Changes in brain functional connectivity in Alzheimer type and multi-infarct dementia. Brain, 115, 1543–1561.
Links, J. M. (1989). Data acquisition, display, and quantification. Journal of Neuropsychiatry and Clinical Neurosciences, 1 (Suppl.), S7–S13.
Loewenstein, D. A., Barker, W. W., Chang, J.-Y, Apicella, A., Yoshii, F., Kothari, P., Levin, B., & Duara, R. (1989). Predominant left hemisphere metabolic dysfunction in dementia. Archives of Neurology, 46, 142–146.
Mahler, M. E., & Cummings, J. L. (1990). Alzheimer disease and the dementia of Parkinson’s disease: Comparative investigations. Alzheimer Disease and Associated Disorders, 14, 133–149.
Martin, A., Brouwers, P., Lalonde, F., Cox, C., Teleska, P., Fedio, P., Foster, N. L., & Chase, T. N. (1986). Towards a behavioral typology of Alzheimer’s disease. Journal of Clinical and Experimental Neuropsychology, 8, 594–610.
Martin, E. M., Wilson, R. S., Penn, R. D., Foss, J. H., Clasen, R. A., & Jaroy, S. M. (1987). Cortical biopsy results in Alzheimer’s disease: Correlation with cognitive deficits. Neurology, 37, 1201–1204.
Martin, W. R. W, Beckman, J. H., Calne, D. B., Adam, M. J., Harrop, R., Rogers, J. G., Ruth, T. J., Sayre, C. I., & Pate, B. D. (1984). Cerebral glucose metabolism in Parkinson’s disease. Canadian Journal of Neurological Science, 11, 169–173.
Martin, W. R. W., Clark, C., Ammann, W., Stoessl, A. J., Shtybel, W., & Hayden, M. R. (1992). Cortical glucose metabolism in Huntington’s disease. Neurology, 42, 223–229.
Masters, C. L., & Richardson, E. P. (1978). Subacute spongiform encephalopathy (Creutzfeldt-Jakob Disease). Brain, 101, 333–344.
Masur, D. M., Fuld, P. A., Blau, A. D., Crystal, H., & Aronson, M. K. (1990). Predicting development of dementia in the elderly with the selective reminding test. Journal of Clinical and Experimental Neuropsychology, 12, 529–538.
Mazziotta, J., & Phelps, M. (1986). Positron emission tomography studies of the brain. In M. Phelps, J. Mazziotta, & H. R. Schelbert (Eds.), Positron emission tomography and autoradiography: Principles and applications for the brain and heart (pp. 493–579). New York: Raven Press.
Mazziotta, J. C., Phelps, M. E., & Carson, R. E. (1982). Topographic mapping of human cerebral metabolism: Sensory deprivation. Annals of Neurology, 12, 435–444.
Mazziotta, J. C., Phelps, M. E., Miller, J., & Kuhl, D. E. (1981). Tomographic mapping of human cerebral metabolism: Normal unstimulated state. Neurology, 31, 503–516.
Mazziotta, J. C., Phelps, M. E., Pahl, J. J., Huang, S.-C., Baxter, L. R., Riege, W. H., Hoffman, J. M., Kuhl, D. E., Lanto, A. B., Wapenski, J. A., & Markham, C. H. (1987). Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington’s disease. New England Journal of Medicine, 316, 357–362.
McCrory, S. J., & Ford, I. (1991). Multivariate analysis of SPECT images with illustrations in Alzheimer’s diseases. Statistics in Medicine, 10, 1711–1718.
McGeer, E. G., McGeer, P. L., Harrop, R., Akiyama, H., & Kamo, H. (1990). Correlates with regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer’s disease. Journal of Neuroscience Research, 27, 612–619.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944.
Mendez, M. F., Adams, N. L., & Lewandowski, S. K. (1989). Neurobehavioral changes associated with caudate lesions. Neurology, 39, 349–354.
Metter, E. J., Kuhl, D. E., & Riege, W. H. (1990). Brain glucose metabolism in Parkinson’s disease. In M. B. Streifler, A. D. Korczyn, E. Melamed, & M. B. H. Youdim (Eds.), Advances in neurology: Vol. 53. Anatomy, pathology, and therapy (pp. 135–139). New York: Raven Press.
Metter, E. J., Riege, W. H., Kuhl, D. E., & Phelps, M. E. (1983). Differences in regional glucose metabolic intercorrelations with aging. Journal of Cerebral Blood Flow and Metabolism, 4, 500–506.
Miller, J. D., de Leon, M. J., Ferris, S. H., Kluger, A., George, A. E., Reisberg, B., Sachs, H. J., & Wolf, A. P. (1987). Abnormal temporal lobe response in Alzheimer’s diseasae during cognitive processing as measured by nC-2-deoxy-D-glucose and PET. Journal of Cerebral Blood Flow and Metabolism, 7, 248–251.
Mirra, S. S., Hart, M. N., & Terry, R. D. (1993). Making the diagnosis of Alzheimer’s disease: A primer for practicing pathologists. Archives of Pathology and Laboratory Medicine, 117, 132–144.
Moeller, J. R., & Strother, S. C. (1991). A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. Journal of Cerebral Blood Flow and Metabolism, 11, A121–A135.
Moss, M. B., & Albert, M. S. (1988). Alzheimer’s disease and other dementing disorders. In M. S. Albert & M. B. Moss (Eds.), Geriatric neuropsychology. New York: Guilford Press.
Naugle, R.L, & Bigler, E. D. (1989). Brain imaging and neuropsychological identification of dementia of the Alzheimer’s type. In E. D. Bigler, R. A. Yeo, & E. Turkheimer (Eds.), Neuropsychological function and brain imaging (pp. 185–218). New York: Plenum Press.
Navia, B. A. (1990). The AIDS dementia complex. In J. Cummings (Ed.), Subcortical dementia (pp. 181–198). New York: Oxford University Press.
Neary, D., Snowden, J. S., Northen, B., & Goulding, P. (1988). Dementia of the frontal lobe type. Journal of Neurology, Neurosurgery, and Psychiatry, 51, 353–361.
Nierenberg, A. A., & Feinstein, A. R. (1988). How to evaluate a diagnostic marker test: Lessons from the rise and fall of the dexamethasone suppression test. Journal of the American Medical Association, 259, 1699–1702.
Palella, T. D., Hichwa, R. D., Ehrenkaufer, R. L., Rothley, J. M., McQuillan, M. A., Young, A. B., & Kelley, W. N. (1985). 18F-fluorodeoxyglucose PET scanning in HPRT deficiency. American Journal of Human Genetics, 37, A70.
Pantano, P., Baron, J. C., Samson, Y., Bousser, M. G., Derouesne, C., & Comar, D. (1986). Crossed cerebellar diaschisis: Further studies. Brain, 109, 677–694.
Pappata, S., Tran Dinh, S., Baron, J. C., Cambon, H., & Syrota, A. (1987). Remote metabolic effects of cerebrovascular lesions: Magnetic resonance and positron tomography imaging. Neuroradiology, 29, 1–6.
Parks, R. W., Loewenstein, D. A., & Chang, J. Y. (1988). Brain imaging: Positron emission tomography and cognitive functioning. In J. M. Williams, & C. J. Long (Eds.), Cognitive approaches to neuropsychology (pp. 189–210). New York: Plenum Press.
Pawlik, G., & Heiss, W. D. (1989). Positron emission tomography and neuropsychological function. In E. D. Bigler, R. A. Yeo, & E. Turkheimer (Eds.), Neuropsychological function and brain imaging (pp. 65–138). New York, London: Plenum Press.
Pearson, R. C. A., Esiri, M. M., Hjorns, R. W., Wilcock, G. K., & Powell, T. P. S. (1985). Anatomical correlates of the distribution of pathological changes in the neocortex in Alzheimer’s disease. Proceedings of the National Academy Sciences, 82, 4531–4534.
Pelizzari, C. A., Chen, G. T., Spelbring, D. R., Weischselbaum, R. R., & Chen, C. T. (1989). Accurate three-dimensional registration of CT., PET., and/or MRI images of the brain. Journal of Computer Assisted Tomography, 13, 20–26.
Penney, J. B., & Young, A. B. (1988). Huntington’s diseasae. In J. Jankovic & E. Toloso (Eds.), Parkinson’s disease and movement disorders, (pp. 167–178). Baltimore: Urban & Schwarzenberg Press.
Peppard, R. F., Martin, W. R. W., Carr, G. D., Grochowski, E., Schulzer, M., Guttman, M., McGeer, P. L., Phillips, A. G., Tsui, J. K. C., & Calne, D. B. (1992). Cerebral glucose metabolism in Parkinson’s disease with and without dementia. Archives of Neurology, 49, 1262–1268.
Perlmutter, J. S. (1988). New insights into the pathophysiology of Parkinson’s disease: The challenge of positron emission tomography. Trends in Neurosciences, 11, 203–207.
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978). Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal, 2, 1457–1459.
Peterson, S. E., Fox, P. T., Posner, M. I., Mintun, M., & Raichle, M. E. (1988). Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature, 331, 585–589.
Peterson, S. E., Fox, P. T., Posner, M. I., Mintun, M., & Raichle, M. E. (1989). Positron emission tomographic studies of the cortical anatomy of single words. Journal of Cognitive Neuroscience, 1, 153–170.
Phelps, M. E., Kuhl, D. E., & Mazziotta, J. C. (1981). Metabolic mapping of the brain’s response to visual stimulation: Studies in man. Science, 211, 1445–1448.
Pietrini, P., Grady, C. L., Haxby, J. V., Heston, L., Salerno, J. A., Gonzales-Aviles, A., & Shapiro, M. B. (1991). Resting cerebral glucose metabolism (CMRglc) does not identify subjects “at risk” for familial Alzheimer disease. Annals of Neurology, 30, 287–288.
Podoll, K., Caspary, P., Lange, H. W., & Noth, J. (1988). Language functions in Huntington’s disease. Brain, 111, 1475–1503.
Posner, M. I., & Petersen, S. E. (1989). The attention system of the human brain. Annual Review of Neurosciences, 13, 25–42.
Powers, W. J., Perlmutter, J. S., Videen, T. O., Herscovitch, P., Griffeth, L. K., Royal, H. D., Siegel, B. A., Morris, J. C., & Berg, L. (1992). Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer’s disease. Neurology, 42, 765–770.
Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science, 216, 136–144.
Raichle, M. E. (1979). Quantitative in vivo autoradiography with positron emission tomography. Brain Research Reviews, 1, 47–68.
Raichle, M. E. (1982). Positron emission tomography. In R. A. Thompson & J. R. Green (Eds.), New perspectives in cerebral localization. New York: Raven Press.
Rao, S. M. (1990). Multiple sclerosis. In J. Cummings (Ed.), Subcortical dementia (pp. 164–180). New York: Oxford University Press.
Rapoport, S. I. (1991). Positron emission tomography in Alzheimer’s disease in relation to disease pathogenesis: A critical review. Cerebrovascular and Brain Metablism Reviews, 3, 297–335.
Rebok, G., Brandt, J., & Folstein, M. (1990). Longitudinal cognitive decline in patients with Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 3, 91–97.
Reichman, W. E., & Cummings, J. L. (1990). Diagnosis of rate dementia syndromes: An algorithmic approach. Journal of Geriatric Psychiatry and Neurology, 3, 73–84.
Richardson, J. C., Steele, J., & Olszewski, J. (1963). Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia: A clinical report on eight cases of “heterogenous system degeneration.” Transactions of the American Neurological Association, 88, 25–29.
Riege, W. H., & Metter, E. J. (1988). Cognitive and brain imaging measures of Alzheimer’s disease: Review. Neurobiology of Aging, 9, 69–86.
Rinne, J. O., Rummukainen, J., Paljarvi, L., & Rinne, U. K. (1989). Dementia in Parkinson’s disease is related to neuronal loss in the medial substantia nigra. Annals of Neurology, 26, 47–50.
Roman, G. C. (1991). The epidemiology of vascular dementia. In A. Hartmann, W. Kuschinsky, & S. Hoyer (Eds.), Cerebral ischemia and dementia (pp. 9–15). Berlin: Springer-Verlag.
Roman, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., Moody, D. M., Obrien, M. D., Yamaguchi, T., Grafman, J., Drayer, B. P., Bennett, D. A., Fisher, M., Ogata, J., Kokmen, E., Bermego, F., Wolf, P. A., Gorelick, P. B., Bick, K. L., Pajeau, A. D., Bell, M. A., DeCarli, C., Culebras, A., Korczyn, A. D., Bogousslavsky, J., Hartmann, A., & Scheinberg, P. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250–260.
Roos, R., Gajdusek, D. C., & Gibbs, C. J. (1973). The clinical characteristics of transmissible Creutzfeldt-Jakob disease. Brain, 96, 1–20.
Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R., & Peck, A. (1980). Pathological verficiation of ischemic score in differentiation of dementias. Annals of Neurology, 7, 486–488.
Rosenblum, W. I., & Ghatak, N. R. (1979). Lewy bodies in the presence of Alzheimer’s disease. Archives of Neurology, 36, 170–171.
Rougemont, D., Baron, J. C., Collard, P., Bustany, P., Comar, D., & Agid, Y. (1984). Local cerebral glucose utilization in treated and untreated patients with Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 824–830.
Rutgers, A. W. F., Lakke, J. P. W. F., Panns, A. M. J., Vaalburg, W, & Korf, J. (1987). Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET). Journal of the Neurological Sciences, 80, 237–248.
Salmon, D. P., Kwoon Yuen, P. R., Heindel, W. C., Butters, N., & Thal, L. J. (1989). Differentiation of Alzheimer’s disease and Huntington’s disease with the dementia rating scale. Archives of Neurology, 46, 1204–1208.
Salmon, E., & Franck, G. (1989). Positron emission tomographic study in Alzheimer’s diseasae and Pick’s disease. Archives of Gerontology and Geriatrics, 1 (Suppl.), 241–247.
Satz, P. (1993). Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology, 7, 273–295.
Scheinberg, P. (1988). Dementia due to vascular disease-A multifactorial disorder. Stroke, 19, 1291–1299.
Schellenberg, G. D., Bird, T. D., Wijsman, E. M., Orr, H. T., Anderson, L., Nemens, E., White, J. A., Bonnycastel, L., Weber, J. L., Alonso, M. E., Potter, H., Heston, L. L., & Martin, G. M. (1992). Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science, 258, 668–671.
Schonfeld, S. M., Golbe, L. I., Sage, J. I., Safer, J. N., & Duvoisin, R. C. (1987). Computed tomographic findings in progressive supranuclear palsy: Correlation with clinical grade. Movement Disorders, 2, 263–278.
Siegler, I. C., Welsh, K. A., Dawson, D. V, Fillenbaum, G. G., Earl, N. L., Kaplan, E. B., & Clark, C. M. (1991). Ratings of personality change in patients being evaluated for memory disorders. Alzheimer’s Disease and Associated Disorders, 3, 240–250.
Smith, G. S., de Leon, M. J., George, A. E., Kluger, A., Volkow, N. D., McGrae, T., Golomb, J., Ferris, S. H., Reisberg, B., Ciaravino, J., & La Regina, M. E. (1992). Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer’s disease: Pathopohysiologic implications. Archives of Neurology, 49, 1142–1150.
Sokoloff, L., Reivich, M., Kennedy, C., Des Rosiers, M. H., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977). The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. Journal of Neurochemistry, 28, 897–916.
Starkstein, S. E., Folstein, S. E., Brandt, J., Pearlson, G. D., McDonnell, A., & Folstein, M. (1989). Brain atrophy in Huntington’s disease. A CT-scan study. Neuroradiology, 31, 156–159.
Stehling, M. K., Turnera, R., & Mansfield, P. (1991). Echo-planar imaging: Magnetic resonance imaging in a fraction of a second. Science, 254, 43–50.
Stern, Y., Alexander, G. E., Prohovnik, I., & Mayeux, R. (1992). Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer’s disease. Annals of Neurology, 32, 371–373.
St. George-Hyslop, G., Tanzi, R., Polinsky, R., Haines, J. L., Nee, L., Watkins, P. C., Myers, R. H., Feldman, R. G., Pilleri, A., Drachman, D., Growdon, J., Bruni, A., Foncin, J. F., Salvion, D., Frannelt, P., Amaducci, L., Sorbi, S., Piacentino, S., Steward, G. D., Hobbs, W., Conneally, P. M., & Gusella, J. F. (1987). The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science, 235, 885–889.
Storandt, M., Botwinick, R. J., Danziger, W. L., Berg, L., & Hughes, C. P. (1984). Psychometric differentiation of mild senile dementia of the Alzheimer type. Archives of Neurology, 41, 497–499.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993). Apolipoprotein E: High affinity binding to beta amyloid and increased frequency of type 4 allele in late onset familial Alzheimer’s. Proceedings of the National Academy of Sciences, 90, 1977–1981.
Suchowersky, O., Hayden, M. R., Martin, M. R. W., Stoessl, A. J., Hildebrand, A. M., & Pate, B. D. (1986). Cerebral metabolism of glucose in benign hereidtary chorea. Movement Disorders, 1, 33–46.
Tatemichi, T. K. (1990). How acute brain failure becomes chronic: A view of the mechanisms of dementia related to stroke. Neurology, 40, 1652–1659.
Tedroff, J., Aquilonius, S.-M., Hartvig, P., Lundqvist, H., Gee, A. G., Uhlin, J., & Långström, B. (1988). Monoamine re-uptake sites in the human brain evaluated by means of 11C-nomifensine and positron emission tomography: The effects of age and Parkinson’s disease. Acta Neurologica Scandinavica, 77, 192–201.
Thompson, P. D., Berardelli, A., Rothwell, J. C., Day, B. L., Dick, J. P. R., Benecke, R., & Marsden, C. D. (1988). The coexistence of bradykinesia and chorea in Huntington’s disease and its implications for theories of basal ganglia control of movement. Brain, 111, 223–244.
Tierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., & Nieuwstraten, P. (1988). The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable AD: A clinicopathologic study of 57 cases. Neurology, 38, 359–364.
Tomlinson, B. E., Blessed, G., & Roth, M. (1968). Observations on the brains of nondemented old people. Journal of the Neurological Sciences, 7, 331–356.
Tomlinson, B. E., Blessed, G., & Roth, M. (1970). Observations on the brains of demented old people. Journal of the Neurological Sciences, 11, 205–242.
Tomlinson, B. E., & Henderson, G. (1976). Some quantitative cerebral findings in normal and demented old people. In R. D. Terry & S. Gershon (Eds.), Neurobiology of aging (pp. 183–204). New York: Raven Press.
Von Sattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., & Richardson, E. P. (1985). Neuropathological classification of Huntington’s disease. Journal of Neuropathology and Experimental Neurology, 44, 557–559.
Welsh, K. A., Butters, N., Hughes, J., Mohs, R. C., & Heyman, A. (1991). Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Archives of Neurology, 48, 278–281.
Welsh, K. A., Butters, N., Hughes, J., Mohs, R. C., & Heyman, A. (1992). Detection and staging of dementia in Alzheimer’s disease: Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer’s Disease. Archives of Neurology, 49, 448–452.
Welsh, K. A., Hoffman, J. M., & Beam, C. (1994). Positron emission tomography and neuropsychological assessment in the detection of Alzheimer’s disease. Neuropsychological Society: Program & Abstracts, 1, 42.
Welsh, K. A., Hoffman, J. M., Earl, N. L., & Hanson, M. W. (1994). Neural correlates of dementia: Regional brain metabolism and the CERAD neuropsychological battery. Archives of Clinical Neu-ropsychology, 9, 395–409.
Welsh, K. A., Hoffman, J. M., McDonald, W. M., Earl, N. L., & Breitner, J. C. S. (1993). Concordant but different: Cognitive function, cerebral anatomy, and metabolism in monozygotic twins with Alzheimer’s disease. Neuropsychology, 7, 158–171.
Workshop Panel. (1990). National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography. Archives of Internal Medicine, 150, 735–739.
Xuereb, J. H., Tomlinson, B. E., Irving, D., Perry, R. H., Blessed, G., & Perry, E. K. (1990). Cortical and subcortical pathology in Parkinson’s disease: Relationship to parkinsonian dementia. In M. B. Streifler, A. D. Korczyn, E. Melamed, & M. B. H. Youdin (Eds.), Advances in neurobiology: Vol. 53. Parkinson’s disease: Anatomy, pathology, and therapy (pp. 35–40). New York: Raven Press.
Yoshii, F., Barker, W. W., Chang, J. Y., Loewenstein, D., Apicella, A., Smith, D., Boothe, T., Ginsberg, M. D., Pascal, S., & Duara, R. (1988). Sensitivity of glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. Journal of Cerebral Blood Flow and Metabolism, 8, 654–661.
Yoshimura, M. (1983). Cortical changes in the parkinsonian brain: A contribution to the delineation of “diffuse Lewy body disease.” Journal of Neurology, 229, 17–32.
Young, A. B., Penney, J. B., Starosta-Rubinstein, S., Markel, D., Berent, S., Rothley, J., Betley, A., & Hichwa, R. (1987). Normal caudate glucose metabolism in persons at risk for Huntington’s disease. Archives of Neurology, 44, 254–257.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Welsh-Bohmer, K.A., Hoffman, J.M. (1996). Positron Emission Tomography Neuroimaging in Dementia. In: Bigler, E.D. (eds) Neuroimaging II. Human Brain Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1769-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1769-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1771-3
Online ISBN: 978-1-4899-1769-0
eBook Packages: Springer Book Archive